Fugan

N/A

Report date: 2023/09/10 20:00:42
NME

Base Information

Drug NameFugan
Drug Alias NameZL-3101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell movement inhibitorsCytokines inhibitorsInflammation mediators inhibitors
TargetsCytokines
Therapy Area/IndicationsEczema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZai Lab Pty Ltd
Active IndicationsN/A
Inactive IndicationsEczema

Other Information

ATC CodeN/A
Related LinksN/A